A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
Conditions: Prostate Cancer Metastatic Interventions: Radiation: Stereotactic Ablative Body Radiotherapy (SABR); Other: 177Lu-PSMA-617; Drug: Niraparib and Abiraterone Acetate Dual Action Tablet DAT; Drug: Abiraterone Acetate; Drug: Apalutamide; Drug: Androgen Deprivation Therapy (ADT); Drug: Androgen Receptor Signalling Inhibitor (ARSI); Radiation: Local Radiotherapy; Drug: Prednisolone; Drug: Docetaxel Sponsors: University College, London; Cancer Research UK; Novartis; Janssen Pharmaceutica NV Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Conditions: Lung Cancer Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
Conditions: Breast Cancer; Lung Cancer; Melanoma; Head and Neck Cancer; Urothelial Carcinoma; Colorectal Cancer; Liver Metastases; Lung Metastases Interventions: Genetic: Cohort A: primarily operable disease, candidate to adjuvant; Genetic: Cohort B: locally advanced disease; Genetic: Cohort C: metastatic disease; Genetic: Cohort D: Progressive disease; Genetic: Cohort E: Hematological neoplasms; Genetic: Cohort F: Toxicity Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Study Evaluating the Feasibility of an Adapted Physical Activity Program During the Hospitalization Phase in Cancer Patients Undergoing Treatment
Conditions: Cancer Interventions: Other: adapted physical activity program (APA Program) Sponsors: Centre Hospitalier Universitaire de Besancon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

The Role of tHyroid cAncer Specific Patient Concerns iNventory (PCI-TC) in Enhancing Shared decisiOn Making
Conditions: Thyroid Cancer Interventions: Other: Interview Sponsors: Royal Marsden NHS Foundation Trust; ENTUK Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)
Conditions: Non-small Cell Lung Cancer Interventions: Drug: Botensilimab + Balstilimab Sponsors: Immune Oncology Research Institute; Agenus Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Effects of Oxygen After Abdominal Oncological Surgery
Conditions: Abdominal Cancer Interventions: Procedure: Oxygen Sponsors: Jules Bordet Institute Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Conditions: Non-Muscle Invasive Bladder Cancer Interventions: Combination Product: TAR-210; Drug: Gemcitabine; Drug: MMC Sponsors: Janssen Research& Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

POZIKIDS: Exercise and Comprehensive Care to Improve the Quality of Life of Children and Adolescents With Cancer
Conditions: Exercise; Childhood Cancer Interventions: Other: Physical exercise program; Other: Type of the physical exercise program Sponsors: Nere Mendizabal Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Other: Blood sample Sponsors: Roswell Park Cancer Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Evaluation of the Effect of a Physical Activity Recovery Stay
Conditions: Children With Cerebral Palsy; Children With Cancer Sponsors: Union de Gestion des Etablissements des Caisses d ' Assurance Maladie - Nord Est Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Fixed Low-dose Simethicone Combined With Macrogol 4000 (PEG) Reduces Colon Bubble Formation in Colonoscopy
Conditions: Colorectal Cancer; Colonoscopy; Bowel Preparation Solution Interventions: Drug: Simethicone combined with Macrogol 4000 (PEG) Sponsors: Hospital St. Joseph, Marseille, France Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Conditions: Platinum-resistant Ovarian Cancer; Recurrent Ovary Cancer; Ovarian Cancer; Ovarian Carcinoma; Ovarian Carcinoma, Recurrent Interventions: Biological: Cytokine-Induced Memory-like Natural Killer Cells; Biological: IL-15 Superagonist Sponsors: Dana-Farber Cancer Institute; ImmunityBio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone
Conditions: Castration-resistant Prostate Cancer Interventions: Procedure: Imaging evaluation Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs
Conditions: Lung Cancer; Blood Biomarkers Interventions: Diagnostic Test: Artificial Intelligence risk model Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Milano Bicocca Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials